- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lack of testing facilities: Centre waives testing requirement for SII Cy-Tb injection at Govt labs
![Lack of testing facilities: Centre waives testing requirement for SII Cy-Tb injection at Govt labs Lack of testing facilities: Centre waives testing requirement for SII Cy-Tb injection at Govt labs](https://medicaldialogues.in/h-upload/2023/01/11/750x450_197442-serum-institute-of-india-3.webp)
New Delhi: The Centre has waived the requirement for testing of Cy-Tb injection, meant for detection of latent tuberculosis and manufactured by the Serum Institute, at government laboratories due to lack of testing facilities in state-run set ups, official sources said. The move comes after Prakash Kumar Singh, Director, Serum Institute of India wrote to the Union health ministry on April 24 and subsequently on May 30 in this regard, they said.
India is committed to eliminate Tuberculosis by 2025, five years ahead of the target for TB set by Sustainable Development Goals 2030.
Serum Institute of India is an Indian biotechnology and biopharmaceuticals company headquartered in Pune, India. The company was founded by Dr. Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751